Abstract
In this paper, we develop a Markov chain model to estimate parameters pertaining to the natural history of nasopharyngeal carcinoma (NPC). The model is of progression from no disease to Epstein–Barr virus (EBV) infection, preclinical screen-detectable tumour and clinical tumour. We derive tentative estimates of the parameters of the model, based on limited published data, to assess the efficacy of serum screening in conjunction with clinical assessment (indirect mirror examination for NPC), for example the average duration of the preclinical screen-detectable phase is estimated as 3.1 years. We further apply these parameters to a hypothetical screening trial in the Hong Kong population to assess the efficacy of serum screening with clinical assessment by different combinations of screening regime. Results suggest: (1) there is no substantial difference between 3-yearly and 6-yearly serum screening; and (2) within the same serum screening regime annual and 3-yearly clinical assessment can prevent 33% and 28% of deaths from NPC respectively. Prediction of deaths and surrogate end points can be used to estimate the required sample size and duration for designing a randomized trial of screening for NPC. Based on these findings and power projections, we suggest a design for a randomized trial in a high incidence area such as Hong Kong. © 1999 Cancer Research Campaign
Full Text
The Full Text of this article is available as a PDF (120.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Duffy S. W., Chen H. H., Tabar L., Day N. E. Estimation of mean sojourn time in breast cancer screening using a Markov chain model of both entry to and exit from the preclinical detectable phase. Stat Med. 1995 Jul 30;14(14):1531–1543. doi: 10.1002/sim.4780141404. [DOI] [PubMed] [Google Scholar]
- Lanier A., Bender T., Talbot M., Wilmeth S., Tschopp C., Henle W., Henle G., Ritter D., Terasaki P. Nasopharyngeal carcinoma in Alaskan Eskimos Indians, and Aleuts: a review of cases and study of Epstein-Barr virus, HLA, and environmental risk factors. Cancer. 1980 Nov 1;46(9):2100–2106. doi: 10.1002/1097-0142(19801101)46:9<2100::aid-cncr2820460932>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
- Sham J. S., Choy D. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br J Radiol. 1990 Jan;63(745):51–58. doi: 10.1259/0007-1285-63-745-51. [DOI] [PubMed] [Google Scholar]
- Yi Z., Yuxi L., Chunren L., Sanwen C., Jihneng W., Jisong Z., Huijong Z. Application of an immunoenzymatic method and an immunoautoradiographic method for a mass survey of nasopharyngeal carcinoma. Intervirology. 1980;13(3):162–168. doi: 10.1159/000149121. [DOI] [PubMed] [Google Scholar]
- Zeng Y., Liu Y., Liu C. R., Chen S. W., Wei J. E., Zhu J. S., Zai H. J. [Application of immunoenzymic method and immunoautoradiographic method for the mass survey of nasopharyngeal carcinoma (author's transl)]. Zhonghua Zhong Liu Za Zhi. 1979;1(1):2–7. [PubMed] [Google Scholar]
- Zeng Y. Seroepidemiological studies on nasopharyngeal carcinoma in China. Adv Cancer Res. 1985;44:121–138. doi: 10.1016/s0065-230x(08)60027-5. [DOI] [PubMed] [Google Scholar]
- Zeng Y., Zhang L. G., Wu Y. C., Huang Y. S., Huang N. Q., Li J. Y., Wang Y. B., Jiang M. K., Fang Z., Meng N. N. Prospective studies on nasopharyngeal carcinoma in Epstein-Barr virus IgA/VCA antibody-positive persons in Wuzhou City, China. Int J Cancer. 1985 Nov 15;36(5):545–547. doi: 10.1002/ijc.2910360505. [DOI] [PubMed] [Google Scholar]
- Zong Y. S., Sham J. S., Ng M. H., Ou X. T., Guo Y. Q., Zheng S. A., Liang J. S., Qiu H. Immunoglobulin A against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer. 1992 Jan 1;69(1):3–7. doi: 10.1002/1097-0142(19920101)69:1<3::aid-cncr2820690104>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]